Find your next paid study

City of Hope Medical CenterNCT07224724

~$10 – $750

Actual pay is set by the research site.

Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases

This is a single-center, open-label, multi-cohort Phase II study evaluating the efficacy and safety of pembrolizumab in combination with lenvatinib in patients…

Brain MetastasesTumor

M.D. Anderson Cancer CenterNCT05064280

Actual pay is set by the research site.

Brain MetastasesHR+ Metastatic Breast Cancer

Phase I/II Study of Stereotactic Radiation and Abemaciclib With or Without Imlunestrant in the Management of Hormone Receptor Positive HER2 Negative Breast Cancer Brain Metastases (STRONG Trial)

This is a single arm study of abemaciclib and endocrine therapy with stereotactic radiosurgery (SRS) among patients with hormone receptor (HR)+/HER2- metastati…

H. Lee Moffitt Cancer Center and Research InstituteNCT04923542

~$150 – $3,000

Actual pay is set by the research site.

Lung CancerLung Cancer MetastaticBrain Metastases+1 more

Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography for Staging, Response Assessment, and Patient Selection in Metastatic Non-Small Cell Lung Cancer

This study investigates fluorine-18-AlphaVBeta6-BP (\[18F\]-αvβ6-BP) as a Positron Emission (PET) imaging agent in Non-Small Cell Lung Cancer (NSCLC) patients …

University of California, DavisNCT05452005

~$150 – $3,000

Actual pay is set by the research site.

Metastatic Breast CancerHER2-negative Breast CancerER+ Breast Cancer+7 more

Phase 1b/2 Open-label Trial of 225Ac-DOTATATE (RYZ101) in Subjects With Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)-Negative, Locally Advanced and Unresectable or Metastatic Breast Cancer Expressing Somatostatin Receptors (SSTRs) (TRACY-1).

Phase 1b/2 open-label trial of 225Ac-DOTATATE (RYZ101) in subjects with ER+, HER2-negative unresectable or metastatic breast cancer expressing SSTRs.

~$150 – $4,200

Actual pay is set by the research site.

Gastric NeoplasmsEsophageal CancerLiver Cancer+9 more

A Phase I Dose-Escalation Trial of vvDD-hIL2-2-RG-1 (Vaccina Virus Double Deleted) Administered by Intra-tumoral (IT) Injection for Metastatic Gastrointestinal and Peritoneal Tumors

This research study aims to evaluate the safety and determine the optimal dose of a new experimental drug, vvDD-hIL2 (vaccinia virus double-deleted human inter…

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)NCT07001592

~$150 – $4,500

Actual pay is set by the research site.

Brain CancerBrain MetastasesMelanoma+13 more

A Double-blind, Phase II Randomized Study of Brain-directed Stereotactic Radiation With or Without AGuIX Gadolinium-based Nanoparticles in the Management of Brain Metastases at Higher Risk of Local Recurrence With Radiation Alone

The purpose of this study is to determine whether AGuIX (Activation and Guidance of Irradiation by X-ray) gadolinium-based nanoparticles make radiation work mo…

Brigham and Women's HospitalNCT04899908

Actual pay is set by the research site.

Bone PainMetastatic Bone TumorBone Metastases in Subjects With Advanced Cancer

A Phase 1 Pharmacokinetic, Dosimetry, Safety, and Dose Optimization Study for a Single Dose of TLX090-Tx (153SmDOTMP) to Treat Metastatic Bone Pain

This is an open label, 2-part early phase study designed to evaluate the safety, pharmacokinetics, radiation dosimetry, and preliminary efficacy of TLX090-Tx i…

Telix Pharmaceuticals (Innovations) Pty LimitedNCT07197645

~$150 – $4,200

Actual pay is set by the research site.

Observational

Intensive Multi-Disciplinary Care Initiative for Patients With Newly Diagnosed Brain Metastases

This is a health services intervention study aimed at understanding the impact of intensive multi-disciplinary care compared with standard care on patient-repo…

Brain Metastases, Adult

University of Vermont Medical CenterNCT06280300

~$10 – $750

Actual pay is set by the research site.

Laser Interstitial Thermal Therapy (LITT) or Surgery and Adjuvant Reirradiation for Recurrent Brain Metastases (LaSAR BeaM)

standard paradigm for management of patients who present with concern for recurrence of brain metastases following initial stereotactic radiosurgery (SRS).

Brain Metastases

M.D. Anderson Cancer CenterNCT07053033

Actual pay is set by the research site.

Observational

Phase I-II Trial of Stereotactic Body Proton Therapy for Patients With Liver Metastases

Local control of hepatic metastases appears to be a major determinant of overall survival. However, many patients are not suitable for resection due to medical…

Liver Metastases

Loma Linda UniversityNCT01697371

~$10 – $750

Actual pay is set by the research site.

Liver CancerIntrahepatic CholangiocarcinomaLiver Metastases+1 more

Phase II Trial of REal Time MRI GUided Adaptive Stereotactic Ablative Radiotherapy for Liver Cancers Using a Single Session, Simulation Free Workflow

Single arm unblinded study of simulation-free MRI-guided SABR with adaptive replanning in one session for treatment of patients with liver cancers